We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
In the VISCHER Innovation Lab, we not only work in the field of law, we also develop our solutions ourselves as far as possible from a technical point of view.
VISCHER Legal Innovation Lab
Red Ink
Careers
Ikerian, a healthcare software platform company that organizes multimodal data at-scale, closes the first tranche of USD 8m Series B Financing to advance its AI platform alongside.
Mininavident AG, in Liestal, developer and manufacturer of the world’s smallest dynamic navigation system for dental implant placement, was acquired by the Straumann Group, a global leader in tooth replacement, orthodontic solutions and adjacent dental technologies.
Tybourne Capital Management, a global, growth-oriented, fundamental equity investor in public and private markets, recently participated in SkyCell AG's USD 116m Series D financing round.
Warteck Invest is one of the oldest real estate companies listed on the SIX Swiss Exchange and is focusing on residential and business properties in Switzerland. In the rights offering to support the growth strategy of Warteck Invest 61'875 new registered shares were offered (gross proceeds of approximately CHF 94.7 million).
Memo Therapeutics AG, a late-stage biotech company developing a best-in-class BKV-neutralizing anti-body for BKV infection in kidney transplantation, raised CHF 20m as part of an extension of its series C financing round.
Oculis Holding AG (Nasdaq: OCS) completed a financing of approximately $59 million, consisting of the issuance of 5,000,000 of its ordinary shares at a purchase price of $11.75 per share.
Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch for their minimal invasive Root Preservation Technology (RPT).
Artiria Medical SA, a Swiss neurovascular MedTech company developing next-generation neuro-interventional products for stroke and aneurysms, closed a USD 6m series A2 financing round.
GlycoEra AG in Wädenswil, has increased its Series A Financing Round with a substantial additional investment by Bristol Meyer Squibb (BMS).
Proteomedix AG, ein privates Schweizer Diagnostikunternehmen im kommerziellen Stadium, und Blue Water Biotech, Inc.
Displaying results 1 to 10 out of 166
